Pay in 4 interest-free payments of $7.49 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Summary: Retatrutide is taken once weekly as a subcutaneous injection, with doses gradually escalated from a low starting dose up to a studied maximum of 12 mg in Phase 2 trials, though it is not yet approved for use in the UK
Looking at weight-loss thresholds at 80 weeks with 12 mg, nearly all participants lost at least 5% of body weight, and more than 85% lost at least 15%
The team there is all about creating a place where you feel supported through your journey of managing your weight
Sclerostin regulation, microarchitecture, and advanced glycation end-products in the bone of elderly women with type 2 diabetes
US$ 21.77
US$ 28.39
US$ 28.99
US$ 20.81
US$ 29.57
US$ 25.80
US$ 23.95
